BioStem Technologies, Inc. (BSEM) Tops Q3 EPS by 6c

BioStem Technologies, Inc. (OTC: BSEM) reported Q3 EPS of $0.42, $0.06 better than the analyst estimate of $0.36. Revenue for the quarter came in at $82.56 million versus the consensus estimate of $78.22 million.

For earnings history and earnings-related data on BioStem Technologies, Inc. (BSEM) click here.

You May Also Be Interested In

• Sinda opens at $10.80, IPO priced at $12
• Trump: Iran Shot At Least Four One Way Attack Drones At Ships
• Cumberland Pharmaceuticals shares updated DMD cardiac trial data